Pharma Insider Sells 4,772 Shares as 2025 Revenue Hits $883M
A high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Making money from home in your spare time is possible. Explore various options that fit into your busy schedule.
24,286 articlesA high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
A new study shows a $1.1 million dividend portfolio yielding 7% can generate roughly $77,000 per year, surpassing med...
As markets wobble in mid-2026, investors are increasingly pursuing steady dividend cash flow to supplement earnings. ...
Trump pledges temporary gas-price reductions at 25 Philadelphia-area stations ahead of Independence Day as crude pric...
Nvidia's next earnings report may hinge on a single, less-obvious metric. This article explains what that figure is, ...
In a volatile start to 2026, investors are seeking dividend ETFs built survive strategies that combine durable income...
As Dyadic gears up to report dyadic (dyai) 2025 earnings, investors should focus on revenue mix, cash runway, and par...
In a choppy 2026 market, a momentum-focused ETF is gaining attention for its track record of catching leaders while a...
A software engineer stands on the cusp of a potential million tax-free gain startup under QSBS rules, but a five-year...
The weight loss therapy wave has fireworks at the giants, but smart investors look for underrated weight loss stocks ...
A major strategic move lands in Voyager Technologies’ lap as it closes the Astrobotic acquisition while securing a he...
Investors are eyeing OneSpan’s 2025 earnings as the company scales its digital identity and security solutions. This ...